Hoedemaeker RF - Search Results

1

The clinical significance of a small focus of well-differentiated carcinoma at prostate biopsy.

Hoedemaeker RF, Van der Kwast TH, Schröder FH. Hoedemaeker RF, et al. BJU Int. 2003 Dec;92 Suppl 2:92-6. doi: 10.1111/j.1465-5101.2003.04406.x. BJU Int. 2003. PMID: 14983963 Clinical Trial.

2

Comparison of pathologic characteristics of T1c and non-T1c cancers detected in a population-based screening study, the European Randomized Study of Screening for Prostate Cancer.

Hoedemaeker RF, Rietbergen JB, Kranse R, van der Kwast TH, Schröder FH. Hoedemaeker RF, et al. World J Urol. 1997;15(6):339-45. doi: 10.1007/BF01300181. World J Urol. 1997. PMID: 9436283 Clinical Trial.

3

Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study.

Rietbergen JB, Kranse R, Hoedemaeker RF, Kruger AE, Bangma CH, Kirkels WJ, Schröder FH. Rietbergen JB, et al. Among authors: hoedemaeker rf. Urology. 1998 Aug;52(2):237-46. doi: 10.1016/s0090-4295(98)00138-1. Urology. 1998. PMID: 9697788 Clinical Trial.

4

Quantitative immunohistochemistry of androgen receptors in a microsphere model system and in prostate tissue sections.

Houtsmuller AB, Janssen PJ, Nigg AL, Hoedemaeker RF, van der Kwast TH. Houtsmuller AB, et al. Among authors: hoedemaeker rf. Anal Quant Cytol Histol. 1998 Oct;20(5):365-72. Anal Quant Cytol Histol. 1998. PMID: 9801754

5

Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer.

Rietbergen JB, Kruger AE, Hoedemaeker RF, Bangma CH, Kirkels WJ, Schröder FH. Rietbergen JB, et al. Among authors: hoedemaeker rf. J Urol. 1998 Dec;160(6 Pt 1):2121-5. doi: 10.1097/00005392-199812010-00046. J Urol. 1998. PMID: 9817336 Clinical Trial.

6

Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

Schröder FH, van der Maas P, Beemsterboer P, Kruger AB, Hoedemaeker R, Rietbergen J, Kranse R. Schröder FH, et al. J Natl Cancer Inst. 1998 Dec 2;90(23):1817-23. doi: 10.1093/jnci/90.23.1817. J Natl Cancer Inst. 1998. PMID: 9839522 Clinical Trial.

7

Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions.

Hoedemaeker RF, Kranse R, Rietbergen JB, Kruger AE, Schröder FH, van der Kwast TH. Hoedemaeker RF, et al. Cancer. 1999 Jan 1;85(1):145-52. Cancer. 1999. PMID: 9921986 Clinical Trial.

8

Human prostate-specific transglutaminase: a new prostatic marker with a unique distribution pattern.

Dubbink HJ, Hoedemaeker RF, van der Kwast TH, Schröder FH, Romijn JC. Dubbink HJ, et al. Among authors: hoedemaeker rf. Lab Invest. 1999 Feb;79(2):141-50. Lab Invest. 1999. PMID: 10068203

9

The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study.

Rietbergen JB, Hoedemaeker RF, Kruger AE, Kirkels WJ, Schröder FH. Rietbergen JB, et al. Among authors: hoedemaeker rf. J Urol. 1999 Apr;161(4):1192-8. J Urol. 1999. PMID: 10081868 Review.

10

Prostate cancer detection at low prostate specific antigen.

Schröder FH, van der Cruijsen-Koeter I, de Koning HJ, Vis AN, Hoedemaeker RF, Kranse R. Schröder FH, et al. Among authors: hoedemaeker rf. J Urol. 2000 Mar;163(3):806-12. J Urol. 2000. PMID: 10687982 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters